← All products
Unclaimed
Added by IndieMerger from the maker's profile. The maker has not confirmed these deal terms yet, so treat them as a starting point.
Pre-revenue
Self-reported
AI-assisted pharmaceutical patent intelligence for early freedom-to-operate research. It combines AI reasoning with software checks and specialist human review. I conceived, designed and built the product alone; it is in production and preparing to go to market.
The deal
- Type
- Pay per result
- Terms
- 30% recurring on referred customers
- Channels needed
- NewsletterX / TwitterCommunitySEO & content
IndieMerger is not an escrow or arbiter. Terms are agreed between the parties.
Listed by Peter McCann Strain.
0 applications so far.